DOLA PATEL: Open Payments
NPI 1023607140 · TIFTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 16 payments from 4 companies in 2025. Trend: 2023 $306 · 2024 $211 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $205 |
| Alkermes, Inc. | 3 | $57 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: FANAPT, LYBALVI, INGREZZA, ARISTADA, Qelbree.
Industry payments across GA — which companies pay providers there.
